Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy

Sofia Lövestam, Manuel Schweighauser, Shigeo Murayama, Yuko Saito, Taisuke Tomita, Takashi Ando, Kazuko Hasegawa, Mari Yoshida, Airi Tarutani, Masato Hasegawa, Michel Goedert, Sjors H. W. Scheres

TL;DR

This study reveals that in-vitro assembly of α-synuclein, even when seeded with pathological filaments from human brains, does not fully replicate the complex structures found in disease. This suggests that crucial, yet unidentified, factors present in the brain are essential for the faithful propagation of α-synuclein strains, a key mechanism in neurodegenerative diseases like Multiple System Atrophy (MSA).

What Problem Does This Paper Address?

Neurodegenerative diseases like Parkinson's disease, Dementia with Lewy Bodies (DLB), and Multiple System Atrophy (MSA) are characterized by the misfolding and aggregation of α-synuclein protein into filamentous structures. A central hypothesis is that these protein aggregates act like prions, spreading from cell to cell and propagating distinct "strains" of α-synuclein, each with a unique conformation. Understanding how these strains form and propagate is crucial for developing effective treatments. Previous work had determined the atomic structures of α-synuclein filaments from MSA patients. This paper addresses the question of whether these brain-derived pathological seeds can faithfully recreate their own complex structures when used to assemble recombinant α-synuclein in vitro. If in-vitro assembly fails to replicate the brain structures, it implies that other factors beyond just the α-synuclein protein itself are involved in disease pathology.

Methods

The researchers employed cryo-electron microscopy (cryo-EM) as their primary technique to determine the high-resolution structures of α-synuclein filaments. They used seeded assembly, where pre-formed filaments (seeds) from MSA patient brains were added to a solution of recombinant wild-type human α-synuclein to initiate its aggregation. The kinetics of this aggregation were monitored using thioflavin T fluorescence, a common assay for amyloid formation. After assembly, the resulting filaments were analyzed by cryo-EM. For structural determination, they utilized helical reconstruction methods within the RELION software package, a standard approach for analyzing filamentous structures. Atomic modeling was performed using software like Coot and ISOLDE to build detailed atomic models of the filament structures based on the cryo-EM density maps.

Datasets

The primary "dataset" in this study consists of filament preparations extracted from the putamen of three individuals with Multiple System Atrophy (MSA). These preparations served as the "seeds" for the in-vitro assembly experiments. The study also references and compares its findings to existing publicly available cryo-EM structures of recombinant α-synuclein filaments (e.g., PDB entries like 6UFR, 6SSX, 6PEO) and structures of filaments from other diseases like DLB.

Key Insights and Ideas

  • In-vitro replication is incomplete: The most striking finding is that the structures formed by in-vitro seeded assembly of recombinant α-synuclein differ from the original brain-derived seeds, even when using those seeds. This directly challenges the idea that α-synuclein alone, templated by existing fibrils, is sufficient to recapitulate disease-specific structures.
  • Brain milieu matters: The discrepancy strongly suggests that additional factors present in the brain's cellular environment are critical for the faithful propagation of α-synuclein strains. These could include other proteins, lipids, nucleic acids, or post-translational modifications.
  • Strain diversity is complex: The study identified distinct filament types (type 1, 2, and 3) formed from different MSA seeds, highlighting the structural diversity of α-synuclein assemblies. However, the key insight is that the in vitro products of these diverse seeds don't perfectly mirror the seeds themselves.
  • Implications for prion-like spread: This finding has significant implications for understanding how proteinopathies spread. It suggests that the "prion-like" propagation might be more nuanced than simple templating, involving a complex interplay between the protein and its cellular context.

Key Results

  • Seeded assembly of recombinant α-synuclein using MSA brain-derived seeds resulted in the formation of distinct filament types (type 1, type 2, and type 3).
  • Cryo-EM structural analysis revealed that the structures of these in vitro assembled filaments were different from the structures of the original MSA seeds.
  • Specifically, type 3 filaments, assembled from seeds enriched in type II MSA filaments, showed the closest structural overlap with brain-derived type IIB protofilaments, but still differed, particularly in the absence of additional densities seen at the inter-protofilament interfaces in brain filaments.
  • Filaments assembled using seeds from MSA cases 1 and 2 (containing a mix of type I and type II seeds) predominantly formed type 1 and type 2 filaments, suggesting a bias in the in-vitro assembly process.

Limitations and Future Work

  • Unidentified factors: The paper explicitly states that the identity of the "additional, as yet unknown, factors" playing a role in pathology propagation remains to be discovered. This is the central direction for future work.
  • In vitro vs. in vivo: While the study uses brain-derived seeds, the assembly is performed in a simplified in vitro buffer. Future research could explore the effect of adding specific brain components (lipids, nucleic acids, etc.) to the in-vitro system to see if replication improves.
  • Strain definition: The paper highlights that different strains might have different seeding potencies, which complicates the interpretation of prion propagation assays. Further work is needed to understand how these potencies relate to structural differences and the role of the cellular environment.
  • Relevance of modifications: The authors note that post-translational modifications and truncations of α-synuclein found in MSA filaments are not fully understood in terms of their role in filament formation and conformation. Investigating these modifications is a key area for future research.

Summary updated

Abstract

Abstract The propagation of conformational strains by templated seeding is central to the prion concept. Seeded assembly of α-synuclein into filaments is believed to underlie the prion-like spreading of protein inclusions in a number of human neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). We previously determined the atomic structures of α-synuclein filaments from the putamen of five individuals with MSA. Here, we used filament preparations from three of these brains for the in vitro seeded assembly of recombinant human α-synuclein. We find that the structures of the seeded assemblies differ from those of the seeds, suggesting that additional, as yet unknown, factors play a role in the propagation of pathology. Identification of these factors will be essential for understanding the prion-like spreading of α-synuclein proteinopathies.
BibTeX
@inproceedings{lovestam2021seeded,
  author = {Sofia Lövestam and Manuel Schweighauser and Shigeo Murayama and Yuko Saito and Taisuke Tomita and Takashi Ando and Kazuko Hasegawa and Mari Yoshida and Airi Tarutani and Masato Hasegawa and Michel Goedert and Sjors H. W. Scheres},
  title = {{Seeded assembly <i>in vitro</i> does not replicate the structures of α-synuclein filaments from multiple system atrophy}},
  booktitle = {FEBS},
  year = {2021},
  doi = {10.1002/2211-5463.13110},
}
Figure